ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

$0.94
+0.08 (+9.38%)
As of Aug 15, 2:25 AM ET ·
Financial Highlights (FY 2026)
Revenue
11.84M
Net Income
51.41M
Gross Margin
53.7%
Profit Margin
434.2%
Rev Growth
-37.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.7% 53.7% 61.3% 61.3%
Operating Margin -218.9% -197.0% 22.2% 22.8%
Profit Margin 434.2% 412.5% 23.2% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.84M 18.80M 7.77M 7.02M
Gross Profit 6.35M 10.09M 4.76M 4.31M
Operating Income -25,918,022 -37,031,623 1.72M 1.61M
Net Income 51.41M 73.46M 1.80M 1.31M
Gross Margin 53.7% 53.7% 61.3% 61.3%
Operating Margin -218.9% -197.0% 22.2% 22.8%
Profit Margin 434.2% 412.5% 23.2% 18.7%
Rev Growth -37.0% -37.0% +3.8% -2.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 19.50M 20.13M
Total Equity 23.16M 25.61M
D/E Ratio 0.84 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -23,236,371 -35,044,534 2.38M 2.09M
Free Cash Flow 1.78M 1.31M